Plexxikon News
Most Popular Plexxikon Story
PLX4032 - 10 promising late-stage cancer drugs
Plexxikon is sitting pretty right now, largely due to the stellar performance of its lead experimental drug, code named PLX4032. After the Berkeley, CA-based firm and its partner Roche reported Read more...
Latest Headlines
- December 23, 2011
- September 7, 2011
- April 4, 2011
- March 18, 2011
- March 1, 2011
- January 19, 2011
- November 5, 2010
- September 20, 2010
- September 15, 2010
- August 26, 2010
- September 24, 2009
- January 8, 2009
Paid Research Reports
- Trends in mHealth and Telemedicine
- The Global Aesthetic Dermatology Market Outlook
- Future Directions in Regenerative Medicine
- Pipeline Insight: Insulin Antidiabetics – Novel analogs show promise as alternative delivery methods prove less attractive
- Pipeline Insight: Non-insulin Antidiabetics - Rise of the weight-reducers: Once-weekly GLP-1 agonists and novel SGLT-2 inhibitor
- Forecast Insight: Antidiabetics - Diabetes market growth driven by epidemiological trends and rich pipeline
